ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Akebia Therapeutics (AKBA) Technical (Analysis) Reports Akebia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Akebia Therapeutics (AKBA)

Technical Analysis Report for NASDAQ stock AKBA Akebia Therapeutics. Dated: 24 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AKBA Akebia Therapeutics then click here. or read Experts views on Akebia Therapeutics or Forecast & share price targets of Akebia Therapeutics

Akebia Therapeutics Opened at 1.65 and Closed at: 1.70, which is 2.94% of previous session's close. It moved within a range of 1.64 and 1.71
The session was a Bullish session with an average volume of 1508800, which is -82.46% of previous session's volumes.

  • Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.

A Golden cross was found 7 days back on short term averages

Support for tomorrow is 1.67 and resistance for tomorrow is 1.74
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.66, 1.61 resistance for tomorrow's hourly charts is 1.73, 1.75

10 Day SMA for Akebia Therapeutics (AKBA) is 1.65 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Akebia Therapeutics (AKBA) is 1.61 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Akebia Therapeutics (AKBA) is 1.99 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.49 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Akebia Therapeutics is 2.69 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Akebia Therapeutics is at 1.61 and 200 DMA is at 2.69, while 50 DMA and 100 DMA are at 1.99 and 2.49 respectively

Akebia Therapeutics (AKBA) moving average of 20 SMA is at 1.61 and 20 EMA is at 1.66

Akebia Therapeutics (AKBA) moving average of 50 SMA is at 1.99 and 50 EMA is at 1.94

Akebia Therapeutics (AKBA) moving average of 100 SMA is at 2.49 and 100 EMA is at 2.3

Akebia Therapeutics (AKBA) moving average of 200 SMA is at 2.69 and 200 EMA is at 2.29

Akebia Therapeutics has performed better than Theravance Biopharma in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Repligen Corporation in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Uniqure N in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Prothena Corporation in short term. Holding Akebia Therapeutics could be a better choice for now!

National Research has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in National Research, about 2% more returns!

Akebia Therapeutics has performed better than Orthopediatrics Corp in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Innoviva Inc in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Galmed Pharmaceuticals in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Fulgent Genetics in short term. Holding Akebia Therapeutics could be a better choice for now!

Establishment Labs has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Establishment Labs, about 4.31% more returns!

Akebia Therapeutics has performed better than Crispr Therapeutics in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Crinetics Pharmaceuticals in short term. Holding Akebia Therapeutics could be a better choice for now!

Akebia Therapeutics has performed better than Cocrystal Pharma in short term. Holding Akebia Therapeutics could be a better choice for now!

Cerus Corporation has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Cerus Corporation, about 10.13% more returns!

Caredx Inc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Caredx Inc, about 3.86% more returns!

Atricure Inc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Atricure Inc, about 5.63% more returns!

Akebia Therapeutics Technical analysis of indicators

Price action analysis of Akebia Therapeutics (AKBA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Akebia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Akebia Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Akebia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Akebia Therapeutics in short term and BUY signal is strong.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Akebia Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.65 and Akebia Therapeutics AKBA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Akebia Therapeutics AKBA stock. Volume based technical analysis of Akebia Therapeutics AKBA stock is negative.

Akebia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AKBA Akebia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AKBA Experts View which covers a lot of information including buying and selling signals

AKBA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akebia Therapeutics or View Candle Stick Charts here

Chart Akebia Therapeutics (AKBA)  Technical (Analysis) Reports Akebia Therapeutics [

Videos related to: Akebia Therapeutics (AKBA) Technical (Analysis) Reports Akebia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Akebia Therapeutics (AKBA)  Technical (Analysis) Reports Akebia Therapeutics [

 

Back to top